ASB-14 inhibitors are chemical compounds that target and modulate the activity of ASB-14, a member of the ankyrin repeat and SOCS box-containing protein family. This protein family is known for its role in various cellular processes, particularly in ubiquitin-mediated protein degradation. ASB-14 specifically is associated with the regulation of the ubiquitination pathway, where it functions by interacting with cullin-RING ligases, influencing the degradation of specific protein substrates within the cell. By inhibiting ASB-14, these compounds can potentially modulate the stability and turnover of proteins that are essential to maintaining cellular homeostasis.
ASB-14 inhibitors can vary in structure, often designed to fit within the binding site of ASB-14, thereby preventing its normal interaction with its molecular partners. They may possess distinct functional groups that enable them to interact with specific amino acid residues on the ASB-14 protein, thereby altering its activity. Such inhibitors can be used as valuable tools in research to investigate the biological pathways influenced by ASB-14, including protein degradation, cell cycle control, and signal transduction. These compounds are also utilized to better understand the mechanistic role of ASB-14 in cellular functions and the broader ubiquitin-proteasome system. Their study provides insight into the fundamental molecular interactions that govern protein regulation within cells.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As an inhibitor of the JNK signaling pathway, SP600125 could lead to a decrease in ASB-14 expression by inhibiting transcription factors downstream of JNK that are necessary for ASB-14 gene expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
This compound inhibits the MEK1/2 kinases, which could lead to reduced phosphorylation of downstream targets and potentially result in the downregulation of ASB-14 expression through decreased activation of transcription factors. | ||||||